amiodarone has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some case reports have described parkinsonism with amiodarone." | 1.62 | Amiodarone and Parkinsonism: a pharmacovigilance study. ( Durrieu, G; Montastruc, JL, 2021) |
| "Twenty-two patients with Parkinsonism during amiodarone therapy were evaluated by clinical neurological examination and FP-CIT SPECT." | 1.36 | FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up. ( Dethy, S; Hambÿe, AS; Vervaet, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montastruc, JL | 1 |
| Durrieu, G | 1 |
| Hambÿe, AS | 1 |
| Vervaet, A | 1 |
| Dethy, S | 1 |
2 other studies available for amiodarone and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Amiodarone and Parkinsonism: a pharmacovigilance study.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents | 2021 |
FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up.
Topics: Aged; Amiodarone; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Male; Parkinson Diseas | 2010 |